Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242514 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)
A Phase 3 study, sponsored by AstraZeneca.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1,917
- Enrollment target
NCT01242514: Clinical Trial Phase 3 study, sponsored by AstraZeneca.
NCT01242514 is a Phase 3 study that was terminated before completion, run by AstraZeneca. The registered enrollment target is 1,917 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (148% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01242514, a Phase 3 study, was terminated before completion, sponsored by AstraZeneca.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1,917 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients with rheumatoid arthritis (RA).
Primary Outcome
AE = adverse event, bid = twice daily, IP = investigational product, qd = once daily, SAE = serious adverse event
Interventions
- DRUG Fostamatinib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,917 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 3 |
Why NCT01242514 stopped before completion
NCT01242514 is an interventional study that assigns participants to a tested intervention. Its 1,917 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (148% higher).
The record links to 0 conditions, and to 1 intervention - of which Fostamatinib is the first listed.
NCT01242514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01242514 about?
NCT01242514 is a clinical study titled "Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)". The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients with rheumatoid arthritis (RA).
What is the current status of trial NCT01242514?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1,917 participants. The study started on 2011-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01242514?
The interventions under investigation include: Fostamatinib (DRUG).
Who is sponsoring clinical trial NCT01242514?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01242514's enrollment target sits among peer trials
1,917 109th of 2000 higher than 1,892 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- NCT06799117 · 1,912 participants · NA
Adaptive Decision Support for Addiction Treatment Master
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia